Gould Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.9K Hold
110
0.02% 114
2025
Q4
$22.8K Hold
110
0.01% 117
2025
Q3
$20.4K Hold
110
0.01% 120
2025
Q2
$16.8K Hold
110
0.01% 122
2025
Q1
$18.2K Hold
110
0.01% 115
2024
Q4
$15.9K Hold
110
0.01% 125
2024
Q3
$17.8K Hold
110
0.01% 132
2024
Q2
$16.1K Hold
110
0.01% 133
2024
Q1
$17.4K Hold
110
0.01% 128
2023
Q4
$17.2K Hold
110
0.01% 137
2023
Q3
$17.1K Hold
110
0.01% 121
2023
Q2
$18.2K Hold
110
0.01% 127
2023
Q1
$17.1K Hold
110
0.01% 133
2022
Q4
$19.4K Sell
110
-11
-9% -$1.9K 0.02% 117
2022
Q3
$20K Hold
121
0.02% 107
2022
Q2
$21K Hold
121
0.02% 106
2022
Q1
$21K Sell
121
-274
-69% -$46.6K 0.02% 113
2021
Q4
$68K Buy
+395
New +$64.7K 0.05% 73

Other funds holding JNJ

Gould Capital's JNJ Position: Q1 2026 in Review

Gould Capital held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 110 shares worth $26.9K. The position accounts for 0.02% of the portfolio, ranked #114.

Gould Capital first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $68K in Q4 2021. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Gould Capital held 110 shares of Johnson & Johnson worth $26.9K as of Q1 2026.
  • Gould Capital left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.02% of Gould Capital's portfolio in Q1 2026, its #114 holding.
  • Gould Capital first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Gould Capital's Johnson & Johnson position peaked at $68K in Q4 2021.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Gould Capital's 13F filing for Q1 2026, filed 18 May 2026.